Revocit Tablet

About Revocit 1000 mg Tablet

Revocit 1000 mg Tablet contains ferric citrate, an oral iron preparation from Square Pharmaceuticals PLC. It is used in adults with chronic kidney disease, both to control phosphorus levels in dialysis patients and to treat iron deficiency anemia in non-dialysis patients.

There are 4 brands of Ferric Citrate listed in Bangladesh. By unit price, Revocit is among the cheapest of them.

What is Revocit 1000 mg Tablet?

Revocit 1000 mg Tablet is an oral iron preparation containing ferric citrate. It is used in adults with chronic kidney disease for two purposes: to control serum phosphorus levels in patients on dialysis, and to treat iron deficiency anemia in patients not on dialysis. Ferric citrate works by binding phosphate in the gut and by providing iron that the body can absorb. Common side effects include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels. The dose is decided by the doctor based on individual needs and monitoring.

Uses of Revocit

Revocit 1000 mg Tablet is used in adults with chronic kidney disease. In patients on dialysis, it helps control serum phosphorus levels by binding phosphate in the digestive tract. In patients not on dialysis, it is used to treat iron deficiency anemia by providing iron. It is not for use in people with iron overload syndromes. The doctor determines whether this medicine is appropriate based on the patient's condition and test results.

How to use Revocit

Revocit 1000 mg Tablet is taken by mouth with meals. The exact dose and how often to take it are decided by the doctor, who may adjust it based on blood test results and the patient's response. Swallow the tablet whole with water. Do not change the dose without medical advice. If a dose is missed, ask the doctor or pharmacist what to do. Follow the doctor's instructions carefully and attend regular check-ups.

Side effects of Revocit

Common side effects of Revocit 1000 mg Tablet include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels (hyperkalemia). These side effects were reported in at least 5% of patients in studies. Not everyone experiences them. If any side effect bothers you or does not go away, tell your doctor or pharmacist. Do not stop taking the medicine without medical advice.

Safety and precautions

Before starting Revocit 1000 mg Tablet, tell your doctor if you have iron overload syndromes, as the medicine is not suitable for people with this condition. Your doctor will check iron levels before and during treatment because iron absorption may lead to excessive iron stores. The medicine may interact with other drugs, so tell your doctor about all medicines you take. There are no data on its use in pregnancy or breastfeeding; ask your doctor if you are pregnant, planning pregnancy, or breastfeeding. Keep out of reach of children and store below 30°C, away from light and moisture.

Frequently asked questions

What is Revocit 1000 mg Tablet used for and what kind of medicine is it?

Revocit 1000 mg Tablet is an oral iron preparation containing ferric citrate. It is used in adults with chronic kidney disease to control serum phosphorus levels in patients on dialysis and to treat iron deficiency anemia in patients not on dialysis. It is not for people with iron overload syndromes.

What does the dosage form and strength mean for Revocit 1000 mg Tablet?

Revocit comes as a tablet, which is a solid dosage form taken by mouth. The strength is 1000 mg, meaning each tablet contains 1000 mg of ferric citrate. The tablet is available in a pack of 5 x 6 tablets. The doctor decides how many tablets you take and for how long.

Which medicines may interact with Revocit 1000 mg Tablet?

Revocit may interact with other medicines. Your doctor may need to separate the timing of administration or monitor your response or blood levels of other medications. Tell your doctor or pharmacist about all medicines you take, including prescription and over-the-counter drugs, before starting Revocit.

What is the price of Revocit 1000 mg Tablet?

The listed price is ৳ 25.00. For the most up-to-date price and availability, check the website or ask your pharmacist.

Indications

Ferric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. Ferric Citrate is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.

Pharmacology

Hyperphosphatemia in chronic kidney disease on dialysis: Ferric iron binds dietary phosphate in the GI tract and precipitates as ferric phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the GI tract and decreasing absorption, ferric citrate lowers the phosphate concentration in the serum.

Iron deficiency anemia in chronic kidney disease not on dialysis: Ferric iron is reduced from the ferric to the ferrous form by ferric reductase in the GI tract. After transport through the enterocytes into the blood, oxidized ferric iron circulates bound to the plasma protein transferrin, and can be incorporated into hemoglobin.

Dosage & Administration

Hyperphosphatemia in chronic kidney disease on dialysis:
  • Starting dose is 2 tablets orally 3 times per day with meals.
  • Adjust dose by 1 to 2 tablets as needed to maintain serumphosphorus at target levels, up to a maximum of 12 tablets daily. Dose can be titrated at 1-week or longer intervals.
Iron deficiency anemia in chronic kidney disease not on dialysis:
  • Starting dose is 1 tablet orally 3 times per day with meals.
  • Adjust dose as needed to achieve and maintain hemoglobin goal, up to a maximum of 12 tablets daily.

Interaction

When clinically significant drug interactions are expected, consider separation of the timing of administration. Consider monitoring clinical responses or blood levels of the concomitant medication.

Contraindications

Ferric Citrate is contraindicated in patients with iron overload syndromes.

Side Effects

Most common adverse reactions (incidence ≥5%) are discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and hyperkalemia.

Pregnancy & Lactation

There are no available data on Ferric Citrate use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. There are no human data regarding the effect of Ferric Citrate in human milk, the effects on the breastfed child, or the effects on milk production.

Precautions & Warnings

Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores. Increases in serum ferritin and transferrin saturation (TSAT) levels were observed in clinical trials. In a 56-week safety and efficacy trial evaluating the control of serum phosphate levels in patients with chronic kidney disease on dialysis in which concomitant use of intravenous iron was permitted, 55 (19%) of patients treated with Ferric Citrate had a ferritin level >1500 ng/mL as compared with 13 (9%) of patients treated with active control. Assess iron parameters (e.g., serum ferritin and TSAT) prior to initiating Ferric Citrate and monitor iron parameters while on therapy. Patients receiving intravenous iron may require a reduction in dose or discontinuation of intravenous iron therapy.

Overdose Effects

No data are available regarding overdose of Ferric Citrate in patients. In patients with chronic kidney disease, the maximum dose studied was 2,520 mg ferric iron (12 tablets of Ferric Citrate) per day. Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores, especially when concomitant intravenous iron is used.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Ferric Citrate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.